Quanterix Corporation Cost of Revenue
Quanterix Corporation (QTRX) reported Cost of Revenue of $20.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-10
- Quanterix Corporation cost of revenue for the quarter ending 2026-06-30 was $20.23M, a 39.77% increase year-over-year.
- Quanterix Corporation cost of revenue for the quarter ending 2026-03-31 was $20.85M, a 34.55% increase year-over-year.
- Quanterix Corporation cost of revenue for the quarter ending 2025-12-31 was $23.82M, a 83.32% increase year-over-year.
- Quanterix Corporation cost of revenue for the quarter ending 2025-09-30 was $23.03M, a 47.04% increase year-over-year.
- Quanterix Corporation cost of revenue for fiscal 2025 was $73.94M, a 36.12% increase from fiscal 2024.
- Quanterix Corporation cost of revenue for fiscal 2024 was $54.32M, a 12.82% increase from fiscal 2023.
- Quanterix Corporation cost of revenue for fiscal 2023 was $48.14M, a 19.97% decline from fiscal 2022.
- Quanterix Corporation cost of revenue for fiscal 2022 was $60.16M, a 31.40% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $20.23M 10-Q · filed 2026-08-10 | $41.08M 10-Q · filed 2026-08-10 | $64.90M derived: sum of 3 quarters · filed 2026-08-10 | $87.92M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $20.85M 10-Q · filed 2026-05-06 | $44.67M derived: sum of 2 quarters · filed 2026-05-06 | $67.69M derived: sum of 3 quarters · filed 2026-05-06 | $82.17M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $23.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $46.84M derived: sum of 2 quarters · filed 2026-03-02 | $61.32M derived: sum of 3 quarters · filed 2026-08-10 | $73.94M 10-K · filed 2026-03-02 | ||||
| 2025-09-30 | $23.03M 10-Q · filed 2025-11-10 | $37.50M derived: sum of 2 quarters · filed 2026-08-10 | $50.12M 10-Q · filed 2025-11-10 | $65.99M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $14.47M 10-Q · filed 2026-08-10 | $13.18M 10-Q · filed 2025-08-07 | $29.97M 10-Q · filed 2026-08-10 | $27.09M 10-Q · filed 2025-08-07 | $42.96M derived: sum of 3 quarters · filed 2026-08-10 | $58.62M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-03-31 | $15.49M 10-Q · filed 2026-05-06 | $13.92M 10-Q · filed 2025-05-12 | $28.49M derived: sum of 2 quarters · filed 2026-05-06 | $44.15M derived: sum of 3 quarters · filed 2026-05-06 | $56.29M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $12.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $28.65M derived: sum of 2 quarters · filed 2026-03-02 | $40.80M derived: sum of 3 quarters · filed 2026-03-02 | $54.32M 10-K · filed 2026-03-02 | ||||
| 2024-09-30 | $15.66M 10-Q · filed 2025-11-10 | $27.81M derived: sum of 2 quarters · filed 2025-11-10 | $41.33M 10-Q · filed 2025-11-10 | $53.47M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $12.15M 10-Q · filed 2025-08-07 | $14.32M 10-Q · filed 2024-08-08 | $25.66M 10-Q · filed 2025-08-07 | $26.76M 10-Q · filed 2024-08-08 | $37.81M derived: sum of 3 quarters · filed 2025-08-07 | $49.96M derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $13.52M 10-Q · filed 2025-05-12 | $12.44M 10-Q · filed 2024-05-08 | $25.66M derived: sum of 2 quarters · filed 2025-05-12 | $37.81M derived: sum of 3 quarters · filed 2025-05-12 | $49.20M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | $12.14M 10-K/A · filed 2024-12-26 | $24.29M derived: sum of 2 quarters · filed 2024-12-26 | $35.68M derived: sum of 3 quarters · filed 2024-12-26 | $48.14M 10-K · filed 2026-03-02 | $51.72M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $12.15M 10-K/A · filed 2024-12-26 | $13.55M 10-Q · filed 2023-11-08 | $23.54M derived: sum of 2 quarters · filed 2024-12-26 | $36.00M 10-K/A · filed 2024-12-26 | $36.97M 10-Q · filed 2023-11-08 | $49.18M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2023-06-30 | $11.39M 10-K/A · filed 2024-12-26 | $11.89M 10-Q · filed 2023-08-08 | $23.85M 10-K/A · filed 2024-12-26 | $23.42M 10-Q · filed 2023-08-08 | $37.03M derived: sum of 3 quarters · filed 2024-12-26 | $53.37M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2023-03-31 | $12.46M 10-K/A · filed 2024-12-26 | $11.53M 10-Q · filed 2023-05-09 | $25.64M derived: sum of 2 quarters · filed 2024-12-26 | $41.98M derived: sum of 3 quarters · filed 2024-12-26 | $57.17M derived: sum of 4 quarters · filed 2024-12-26 | |||
| 2022-12-31 | $13.18M 10-K/A · filed 2024-12-26 | $29.52M derived: sum of 2 quarters · filed 2024-12-26 | $44.70M derived: sum of 3 quarters · filed 2024-12-26 | $60.16M 10-K · filed 2025-03-17 | $58.72M 10-K · filed 2023-03-06 | |||
| 2022-09-30 | $16.34M 10-K/A · filed 2024-12-26 | $15.70M 10-Q · filed 2022-11-09 | $31.52M derived: sum of 2 quarters · filed 2024-12-26 | $46.98M 10-K/A · filed 2024-12-26 | $45.48M 10-Q · filed 2022-11-09 | $57.96M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2022-06-30 | $15.18M 10-K/A · filed 2024-12-26 | $14.79M 10-Q · filed 2022-08-08 | $30.64M 10-K/A · filed 2024-12-26 | $29.78M 10-Q · filed 2022-08-08 | $41.62M derived: sum of 3 quarters · filed 2024-12-26 | $54.06M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2022-03-31 | $15.46M 10-K/A · filed 2024-12-26 | $14.99M 10-Q · filed 2022-05-10 | $26.44M derived: sum of 2 quarters · filed 2024-12-26 | $38.88M derived: sum of 3 quarters · filed 2024-12-26 | $50.38M derived: sum of 4 quarters · filed 2024-12-26 | |||
| 2021-12-31 | $10.98M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-26 | $23.43M derived: sum of 2 quarters · filed 2024-12-26 | $34.92M derived: sum of 3 quarters · filed 2024-12-26 | $45.78M 10-K/A · filed 2024-12-26 | $48.83M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $12.45M 10-Q · filed 2022-11-09 | $23.94M derived: sum of 2 quarters · filed 2022-11-09 | $34.80M 10-Q · filed 2022-11-09 | $45.88M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $11.50M 10-Q · filed 2022-08-08 | $22.36M 10-Q · filed 2022-08-08 | $33.44M derived: sum of 3 quarters · filed 2022-08-08 | $43.72M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | $10.86M 10-Q · filed 2022-05-10 | $21.94M derived: sum of 2 quarters · filed 2022-05-10 | $32.22M derived: sum of 3 quarters · filed 2022-05-10 | $40.14M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $11.08M 10-K · filed 2021-03-05 | $21.36M derived: sum of 2 quarters · filed 2021-11-04 | $29.28M derived: sum of 3 quarters · filed 2021-11-04 | $38.20M 10-K · filed 2023-03-06 | ||||
| 2020-09-30 | $10.28M 10-Q · filed 2021-11-04 | $18.20M derived: sum of 2 quarters · filed 2021-11-04 | $27.11M 10-Q · filed 2021-11-04 | $36.17M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $7.92M 10-Q · filed 2021-08-05 | $16.83M 10-Q · filed 2021-08-05 | $25.88M derived: sum of 3 quarters · filed 2021-08-05 | $33.79M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $8.91M 10-Q · filed 2021-05-06 | $17.97M derived: sum of 2 quarters · filed 2021-05-06 | $25.88M derived: sum of 3 quarters · filed 2021-05-06 | $32.48M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $9.05M 10-K · filed 2021-03-05 | $16.96M derived: sum of 2 quarters · filed 2021-03-05 | $23.57M derived: sum of 3 quarters · filed 2021-03-05 | $29.90M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $7.91M 10-K · filed 2021-03-05 | $14.52M derived: sum of 2 quarters · filed 2021-03-05 | $20.85M 10-Q · filed 2020-11-06 | $26.52M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2019-06-30 | $6.61M 10-K · filed 2021-03-05 | $12.94M 10-Q · filed 2020-08-04 | $18.60M derived: sum of 3 quarters · filed 2021-03-05 | $23.60M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2019-03-31 | $6.33M 10-K · filed 2021-03-05 | $12.00M derived: sum of 2 quarters · filed 2021-03-05 | $17.00M derived: sum of 3 quarters · filed 2021-03-05 | $21.66M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2018-12-31 | $5.67M 10-K · filed 2020-03-13 | $10.66M derived: sum of 2 quarters · filed 2020-03-13 | $15.34M derived: sum of 3 quarters · filed 2020-03-13 | $19.68M 10-K · filed 2021-03-05 | ||||
| 2018-09-30 | $5.00M 10-K · filed 2020-03-13 | $9.67M derived: sum of 2 quarters · filed 2020-03-13 | $14.02M 10-Q · filed 2019-11-08 | $17.72M derived: sum of 4 quarters · filed 2020-03-13 | ||||
| 2018-06-30 | $4.67M 10-K · filed 2020-03-13 | $9.02M 10-Q · filed 2019-08-06 | $12.73M derived: sum of 3 quarters · filed 2020-03-13 | $15.90M derived: sum of 4 quarters · filed 2020-03-13 | ||||
| 2018-03-31 | $4.35M 10-K · filed 2020-03-13 | $8.06M derived: sum of 2 quarters · filed 2020-03-13 | $11.23M derived: sum of 3 quarters · filed 2020-03-13 | |||||
| 2017-12-31 | $3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $6.88M derived: sum of 2 quarters · filed 2020-03-13 | $12.89M 10-K · filed 2020-03-13 | |||||
| 2017-09-30 | $3.17M 10-Q · filed 2018-11-07 | $9.18M 10-Q · filed 2018-11-07 | ||||||
| 2016-12-31 | $9.84M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |